Patents Assigned to Biogen Idcc MA Inc.
  • Methods of treatment by administering an anti-BCMA antibody
    Patent number: 7083785
    Abstract: A novel receptor in the TNF family is provided: BAFF-R. Chimeric molecules and antibodies to BAFF-R and methods of use thereof are also provided.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: August 1, 2006
    Assignees: Biogen Idcc MA Inc., Apoxis SA
    Inventors: Jeffrey Browning, Christine Ambrose, Fabienne MacKay, Jurg Tschopp, Pascal Schneider, Jeffrey Thompson